Lifecore Biomedical, Inc. (LFCR)

NASDAQ: LFCR · IEX Real-Time Price · USD
6.29
-0.40 (-5.98%)
At close: Apr 22, 2024, 4:00 PM
6.45
+0.16 (2.54%)
After-hours: Apr 22, 2024, 4:31 PM EDT
-5.98%
Market Cap 192.14M
Revenue (ttm) 103.27M
Net Income (ttm) -99.56M
Shares Out 30.55M
EPS (ttm) -3.32
PE Ratio n/a
Forward PE 10.45
Dividend n/a
Ex-Dividend Date n/a
Volume 167,615
Open 6.75
Previous Close 6.69
Day's Range 6.27 - 6.75
52-Week Range 4.06 - 11.46
Beta 1.06
Analysts Buy
Price Target 9.50 (+51.03%)
Earnings Date May 30, 2024

About LFCR

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation... [Read more]

Sector Healthcare
Founded 1986
Employees 459
Stock Exchange NASDAQ
Ticker Symbol LFCR
Full Company Profile

Financial Performance

In 2023, LFCR's revenue was $103.27 million, a decrease of -7.19% compared to the previous year's $111.27 million. Losses were -$99.56 million, -14.70% less than in 2022.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for LFCR stock is "Buy." The 12-month stock price forecast is $9.5, which is an increase of 51.03% from the latest price.

Price Target
$9.5
(51.03% upside)
Analyst Consensus: Buy
Stock Forecasts

News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCR

NEW YORK , April 20, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Lifecore Biomedical, Inc. ("Lifecore" or the "Company") (NASDAQ: LFCR). Such investors are adv...

2 days ago - PRNewsWire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

NEW YORK , April 19, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Lifecore Biomedical ...

3 days ago - PRNewsWire

Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report

CHASKA, Minn., April 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that, on April 15, 2024, the Company received a notification letter (the “Not...

3 days ago - GlobeNewsWire

LFCR INVESTOR NEWS: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

NEW YORK , April 12, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Lifecore Biomed...

10 days ago - PRNewsWire

ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC

NEW YORK--(BUSINESS WIRE)---- $LFCR #LFCR--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Lifecore Biome...

11 days ago - Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / April 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lifecore Biomedi...

11 days ago - Accesswire

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / April 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lifecore Biomedic...

14 days ago - Accesswire

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / April 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lifecore Biomedic...

17 days ago - Accesswire

ONGOING SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / April 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lifecore Biomedic...

18 days ago - Accesswire

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lifecore Biomedi...

24 days ago - Accesswire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Lifecore Biomedic...

25 days ago - Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR) investors concerning the C...

25 days ago - Business Wire

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

NEW YORK--(BUSINESS WIRE)---- $LFCR #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. (“Life...

25 days ago - Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR) on behalf of investors concerning th...

27 days ago - Business Wire

Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update

CHASKA, Minn., March 26, 2024 (GLOBE NEWSWIRE) --  Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO...

27 days ago - GlobeNewsWire

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lifecore Biomedi...

4 weeks ago - Accesswire

Lifecore Class Action Lawsuit Investigation News – Potential to Make Claim, Recover Losses, Contact Johnson Fistel, LLP

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Lifecore Biomedical, Inc. (NASDAQ: LFCR). (“Lifecore” or the “Co...

4 weeks ago - Business Wire

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Lifecore Biomedical, Inc. (LFCR)

NEW YORK--(BUSINESS WIRE)---- $LFCR #Investigation--The law firm of Kirby McInerney LLP is investigating potential claims against Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ:LFCR)....

4 weeks ago - Business Wire

Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes

Appoints Paul Josephs, an executive with 25 years of CDMO experience as CEO, to succeed current CEO James Hall following his retirement

4 weeks ago - GlobeNewsWire

Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023

Efforts now aligned toward the completion of its First Quarter Fiscal 2024 Report on Form 10-Q Efforts now aligned toward the completion of its First Quarter Fiscal 2024 Report on Form 10-Q

4 weeks ago - GlobeNewsWire

Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal

Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company's Securities Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company...

2 months ago - GlobeNewsWire

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements

Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements

3 months ago - GlobeNewsWire

Top 5 Risk Off Stocks That May Explode This Quarter - AgriFORCE Growing Systems (NASDAQ:AGRI), Bit Brother (NASDAQ:BETS)

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Other symbols: AGRIRGFSANW
4 months ago - Benzinga

Lifecore Biomedical Provides Business Update

CHASKA, Minn., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today provid...

4 months ago - GlobeNewsWire

Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods

CHASKA, Minn., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that the U.S. Department of Justice (the “DOJ”) has declined to prosecute the ...

5 months ago - GlobeNewsWire